JTEC

JTEC OCF Margin

The Operating Cash Flow Margin of JTEC (3446.T) as of Oct 19, 2026 is 6.13 %. In the previous year, Operating Cash Flow Margin was 14.88 % — a change of -58.77% (lower).

OCF Margin

6.13 %

YoY

-58.77%

Last updated:

Operating Cash Flow Margin of JTEC is 2026 6.13 % . Operating Cash Flow Margin of JTEC was 2025 14.88 % . It decreases by -58.77% lower compared to the previous year.

The JTEC OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
7.44 JPY
Jan 1, 2020
6.52 JPY
Jan 1, 2021
-17.61 JPY
Jan 1, 2022
24.69 JPY
Jan 1, 2023
11.02 JPY
Jan 1, 2024
3.12 JPY
Jan 1, 2025
14.88 JPY
Jan 1, 2026
6.13 JPY
The JTEC OCF Margin history
YEAROCF MarginYoY
6.13 %-58.77%
14.88 %+377.38%
3.12 %-71.73%
11.02 %-55.36%
24.69 %-240.19%
-17.61 %-369.94%
6.52 %-12.27%
7.44 %+109.95%
3.54 %-3.30%
3.66 %-83.14%
21.73 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JTEC Stock analysis

What does JTEC do? JTEC Corp, listed on the Tokyo Stock Exchange under ticker 3446.T with ISIN JP3386660009, is a Japanese company operating in the Health Care sector. Headquartered in Ibaraki-shi, Japan, the company employs 64 full-time staff. It completed its initial public offering on February 28, 2018. JTEC Corp develops, designs, manufactures, and sells automation systems, focusing on specialized equipment for scientific and medical applications. The company operates through two business segments. The Optical segment specializes in X-ray nano-collecting mirrors used in synchrotron radiation and X-ray free electron laser facilities, designed for advanced analytical applications in both basic research and industrial contexts. The Life Science and Equipment Development segment focuses on automatic cell culture devices and other automation equipment, serving medical, biotechnology, and research sectors. These devices are developed and sold for use in laboratories and research institutions. The company also provides outsourced manufacturing and proprietary products to research institutes and businesses across various industries. JTEC Corp's website is www.j-tec.co.jp, offering further information about its products and services. The company maintains a presence in the health care industry, leveraging automation technology to support scientific research and medical advancements. Its operations reflect a niche focus on precision engineering for specialized applications in high-tech research environments. JTEC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JTEC stock

Operating Cash Flow Margin of JTEC is 6.13 % in 2026.

Operating Cash Flow Margin of JTEC changed from 14.88 % to 6.13 %, representing a -58.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin JTEC since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's JTEC with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — JTEC

All Key Metrics — JTEC